Outlook Therapeutics (OTLK) EPS (2015 - 2026)
Outlook Therapeutics (OTLK) EPS from Dec 31, 2015 to Mar 31, 2026. The TTM Outlook Therapeutics (OTLK) EPS is -$1.11. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Outlook Therapeutics (OTLK) EPS CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -38.57% |
| 5 Years TTM | -28.21% |
| 10 Years TTM | -30.25% |
| All Time TTM | -34.33% |
Annual EPS change of Outlook Therapeutics (OTLK)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.04 | -96.33% |
| 2025 | -$1.16 | -63.26% |
| 2024 | -$3.15 | -30.44% |
| 2023 | -$4.53 | -22.01% |
| 2022 | -$5.81 | -3.55% |
| 2021 | -$6.03 | +7.97% |
| 2020 | -$5.58 | +85.00% |
| 2019 | -$3.02 | -78.24% |
| 2018 | -$13.86 | -21.32% |
| 2017 | -$17.62 | -67.50% |
| 2016 | -$54.20 | +51.68% |
| 2015 | -$35.73 | N/A |
Comparison Outlook Therapeutics (OTLK) five years EPS CAGR with competitors
Outlook Therapeutics (OTLK) five years EPS CAGR is -28.21%.